18 May 2013
Keywords: lectus, acquires, neuroserve, assets, bristol, uk-based, therapeutics
Article | 24 April 2006
Bristol, UK-based Lectus Therapeutics, a drug discovery and development company focusing on next-generation ion channel modulators, has acquired the assets ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.